KPIs & Operating Metrics(New)
Growth Metrics

AbbVie (ABBV) Share-based Compensation (QoQ) (2012 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 182.80%
Dec 31, 2025 -24.88%
Sep 30, 2025 16.76%
Jun 30, 2025 -56.34%
Mar 31, 2025 150.00%
Dec 31, 2024 -9.39%
Sep 30, 2024 -16.97%
Jun 30, 2024 -37.36%
Mar 31, 2024 178.40%
Dec 31, 2023 -3.85%
Sep 30, 2023 -27.37%
Jun 30, 2023 -42.81%
Mar 31, 2023 137.12%
Dec 31, 2022 4.76%
Sep 30, 2022 17.76%
Jun 30, 2022 -65.03%
Mar 31, 2022 137.21%
Dec 31, 2021 -4.44%
Sep 30, 2021 -15.09%
Jun 30, 2021 -40.89%
Mar 31, 2021 97.79%
Dec 31, 2020 -16.05%
Sep 30, 2020 -31.36%
Jun 30, 2020 7.76%
Mar 31, 2020 177.22%
Dec 31, 2019 5.33%
Sep 30, 2019 -13.79%
Jun 30, 2019 -53.97%
Mar 31, 2019 170.00%
Dec 31, 2018 -6.67%
Sep 30, 2018 -11.76%
Jun 30, 2018 -55.50%
Mar 31, 2018 148.05%
Dec 31, 2017 8.45%
Sep 30, 2017 -6.58%
Jun 30, 2017 -46.10%
Mar 31, 2017 88.00%
Dec 31, 2016 8.70%
Sep 30, 2016 -49.64%
Jun 30, 2016 -0.72%
Mar 31, 2016 160.38%
Dec 31, 2015 -3.64%
Sep 30, 2015 0.00%
Jun 30, 2015 -53.78%
Mar 31, 2015 176.74%
Dec 31, 2014 -2.27%
Sep 30, 2014 -10.20%
Jun 30, 2014 -53.77%
Mar 31, 2014 186.49%
Dec 31, 2013 -9.76%
Sep 30, 2013 -10.87%
Jun 30, 2013 -47.13%
Mar 31, 2013 180.65%
Dec 31, 2012 3.33%
Sep 30, 2012 -14.29%
Jun 30, 2012 -61.54%